N@N

Illumina to Announce Fourth Quarter and Fiscal Year 2010 Financial Results on Tuesday, February 8, 2011

_{//health-fitness.news-articles.net/content/2011/ .. inancial-results-on-tuesday-february-8-2011.html}
^{Published in Health and Fitness on Tuesday, January 25th 2011 at 3:21 GMT by Market Wire}  

SAN DIEGO--([ BUSINESS WIRE ])--Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for fourth quarter and fiscal year 2010 following the close of market on Tuesday, February 8, 2011.

On the same day, at 2:30pm Pacific Time (5:30pm Eastern Time) Jay Flatley, President and Chief Executive Officer, and Christian Henry, Senior Vice President, Chief Financial Officer, and General Manager, Life Sciences, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:30pm Pacific Time (5:30pm Eastern Time) on Tuesday, February 8, 2011. Interested parties may listen to the call by dialing 800.561.2813 (passcode: 53294883), or if outside North America, by dialing +1.617.614.3529 (passcode: 53294883). Individuals may access the live teleconference in the Investor Relations section of Illumina's web site under the aCompanya tab at [ www.illumina.com ].

A replay of the conference call will be available from 6:30pm Pacific Time (9:30pm Eastern Time) on February 8, 2011 through February 15, 2011 by dialing 888.286.8010 (passcode: 87212455), or if outside North America, by dialing +1.617.801.6888 (passcode: 87212455).

About Illumina

Illumina ([ http://www.illumina.com ]) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.